CRL Annual CFO
$683.90 M
+$64.26 M+10.37%
30 December 2023
Summary:
As of January 21, 2025, CRL annual cash flow from operations is $683.90 million, with the most recent change of +$64.26 million (+10.37%) on December 30, 2023. During the last 3 years, it has risen by +$137.32 million (+25.12%). CRL annual CFO is now -10.11% below its all-time high of $760.80 million, reached on December 25, 2021.CRL Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly CFO
$251.79 M
+$58.26 M+30.10%
28 September 2024
Summary:
As of January 21, 2025, CRL quarterly cash flow from operations is $251.79 million, with the most recent change of +$58.26 million (+30.10%) on September 28, 2024. Over the past year, it has increased by +$30.85 million (+13.96%). CRL quarterly CFO is now at all-time high.CRL Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL TTM CFO
$796.16 M
+$46.34 M+6.18%
28 September 2024
Summary:
As of January 21, 2025, CRL TTM cash flow from operations is $796.16 million, with the most recent change of +$46.34 million (+6.18%) on September 28, 2024. Over the past year, it has increased by +$112.26 million (+16.41%). CRL TTM CFO is now at all-time high.CRL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.4% | +14.0% | +16.4% |
| 3 y3 years | +25.1% | +14.0% | +16.4% |
| 5 y5 years | +55.0% | +14.0% | +16.4% |
CRL Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -10.1% | +10.4% | at high | +145.3% | at high | +29.6% |
| 5 y | 5-year | -10.1% | +42.2% | at high | +267.1% | at high | +65.5% |
| alltime | all time | -10.1% | +1925.3% | at high | >+9999.0% | at high | >+9999.0% |
Charles River Laboratories International Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $251.79 M(+30.1%) | $796.16 M(+6.2%) |
| June 2024 | - | $193.53 M(+49.0%) | $749.82 M(+6.4%) |
| Mar 2024 | - | $129.89 M(-41.2%) | $704.40 M(+3.0%) |
| Dec 2023 | $683.90 M(+10.4%) | $220.94 M(+7.5%) | $683.90 M(-2.0%) |
| Sept 2023 | - | $205.45 M(+38.7%) | $697.71 M(+11.6%) |
| June 2023 | - | $148.12 M(+35.4%) | $625.04 M(-0.2%) |
| Mar 2023 | - | $109.38 M(-53.4%) | $626.39 M(+1.1%) |
| Dec 2022 | $619.64 M(-18.6%) | $234.76 M(+76.8%) | $619.64 M(+0.9%) |
| Sept 2022 | - | $132.78 M(-11.2%) | $614.14 M(-6.4%) |
| June 2022 | - | $149.47 M(+45.6%) | $656.08 M(-5.4%) |
| Mar 2022 | - | $102.63 M(-55.2%) | $693.20 M(-8.9%) |
| Dec 2021 | $760.80 M(+39.2%) | $229.26 M(+31.2%) | $760.80 M(+13.6%) |
| Sept 2021 | - | $174.72 M(-6.4%) | $669.92 M(-0.4%) |
| June 2021 | - | $186.59 M(+9.6%) | $672.50 M(+3.7%) |
| Mar 2021 | - | $170.23 M(+23.0%) | $648.21 M(+18.6%) |
| Dec 2020 | $546.58 M(+13.6%) | $138.38 M(-22.0%) | $546.58 M(-7.2%) |
| Sept 2020 | - | $177.30 M(+9.2%) | $588.87 M(+3.8%) |
| June 2020 | - | $162.31 M(+136.6%) | $567.42 M(+6.1%) |
| Mar 2020 | - | $68.59 M(-62.0%) | $534.67 M(+11.2%) |
| Dec 2019 | $480.94 M(+9.0%) | $180.68 M(+15.9%) | $480.94 M(+9.2%) |
| Sept 2019 | - | $155.85 M(+20.3%) | $440.23 M(+9.6%) |
| June 2019 | - | $129.55 M(+771.9%) | $401.63 M(+1.4%) |
| Mar 2019 | - | $14.86 M(-89.4%) | $395.95 M(-10.2%) |
| Dec 2018 | $441.14 M(+38.7%) | $139.97 M(+19.4%) | $441.14 M(+3.7%) |
| Sept 2018 | - | $117.24 M(-5.4%) | $425.40 M(+15.7%) |
| June 2018 | - | $123.87 M(+106.3%) | $367.64 M(+6.7%) |
| Mar 2018 | - | $60.05 M(-51.7%) | $344.57 M(+8.3%) |
| Dec 2017 | $318.07 M(+0.4%) | $124.24 M(+108.9%) | $318.07 M(+1.3%) |
| Sept 2017 | - | $59.48 M(-41.0%) | $313.92 M(-3.7%) |
| June 2017 | - | $100.80 M(+200.4%) | $326.08 M(+6.9%) |
| Mar 2017 | - | $33.56 M(-72.1%) | $305.10 M(-3.7%) |
| Dec 2016 | $316.90 M(+3.9%) | $120.08 M(+67.6%) | $316.90 M(-0.1%) |
| Sept 2016 | - | $71.64 M(-10.2%) | $317.14 M(-4.9%) |
| June 2016 | - | $79.82 M(+76.0%) | $333.45 M(-1.7%) |
| Mar 2016 | - | $45.35 M(-62.3%) | $339.38 M(+11.3%) |
| Dec 2015 | $304.96 M(+21.5%) | $120.33 M(+36.8%) | $304.96 M(+7.4%) |
| Sept 2015 | - | $87.95 M(+2.6%) | $283.97 M(+8.0%) |
| June 2015 | - | $85.74 M(+684.0%) | $262.98 M(+12.3%) |
| Mar 2015 | - | $10.94 M(-89.0%) | $234.19 M(-6.7%) |
| Dec 2014 | $251.05 M(+21.2%) | $99.34 M(+48.3%) | $251.05 M(+17.4%) |
| Sept 2014 | - | $66.96 M(+17.6%) | $213.84 M(-0.0%) |
| June 2014 | - | $56.95 M(+104.9%) | $213.89 M(+4.4%) |
| Mar 2014 | - | $27.80 M(-55.3%) | $204.96 M(-1.1%) |
| Dec 2013 | $207.14 M(-0.4%) | $62.12 M(-7.3%) | $207.14 M(-1.1%) |
| Sept 2013 | - | $67.02 M(+39.6%) | $209.53 M(+3.0%) |
| June 2013 | - | $48.02 M(+60.2%) | $203.34 M(-4.4%) |
| Mar 2013 | - | $29.97 M(-53.5%) | $212.60 M(+2.3%) |
| Dec 2012 | $207.90 M | $64.51 M(+6.1%) | $207.90 M(-3.5%) |
| Sept 2012 | - | $60.83 M(+6.2%) | $215.43 M(+6.2%) |
| June 2012 | - | $57.28 M(+126.6%) | $202.89 M(-3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $25.28 M(-64.9%) | $209.21 M(+1.9%) |
| Dec 2011 | $205.28 M(+21.5%) | $72.04 M(+49.2%) | $205.28 M(+2.2%) |
| Sept 2011 | - | $48.29 M(-24.1%) | $200.83 M(+18.0%) |
| June 2011 | - | $63.59 M(+197.8%) | $170.17 M(+5.1%) |
| Mar 2011 | - | $21.36 M(-68.4%) | $161.91 M(-4.2%) |
| Dec 2010 | $169.01 M(-24.9%) | $67.59 M(+283.5%) | $169.01 M(+3.3%) |
| Sept 2010 | - | $17.63 M(-68.1%) | $163.58 M(-18.8%) |
| June 2010 | - | $55.34 M(+94.4%) | $201.54 M(-6.9%) |
| Mar 2010 | - | $28.46 M(-54.2%) | $216.39 M(-3.8%) |
| Dec 2009 | $225.04 M(-19.6%) | $62.16 M(+11.8%) | $225.04 M(-8.4%) |
| Sept 2009 | - | $55.59 M(-20.8%) | $245.67 M(-5.7%) |
| June 2009 | - | $70.18 M(+89.1%) | $260.39 M(-8.8%) |
| Mar 2009 | - | $37.12 M(-55.2%) | $285.38 M(+1.9%) |
| Dec 2008 | $279.95 M(-1.5%) | $82.79 M(+17.7%) | $279.95 M(-10.6%) |
| Sept 2008 | - | $70.31 M(-26.1%) | $313.00 M(-2.1%) |
| June 2008 | - | $95.17 M(+200.4%) | $319.87 M(+14.5%) |
| Mar 2008 | - | $31.68 M(-72.6%) | $279.44 M(-1.7%) |
| Dec 2007 | $284.25 M(+72.9%) | $115.84 M(+50.1%) | $284.25 M(+26.2%) |
| Sept 2007 | - | $77.18 M(+41.0%) | $225.16 M(+15.5%) |
| June 2007 | - | $54.74 M(+50.0%) | $194.95 M(-2.8%) |
| Mar 2007 | - | $36.49 M(-35.7%) | $200.53 M(+22.0%) |
| Dec 2006 | $164.37 M(-29.9%) | $56.75 M(+20.8%) | $164.37 M(-14.0%) |
| Sept 2006 | - | $46.97 M(-22.1%) | $191.03 M(-11.5%) |
| June 2006 | - | $60.32 M(>+9900.0%) | $215.86 M(+6.3%) |
| Mar 2006 | - | $326.00 K(-99.6%) | $203.00 M(-13.5%) |
| Dec 2005 | $234.55 M(+26.9%) | $83.41 M(+16.2%) | $234.55 M(+3.9%) |
| Sept 2005 | - | $71.80 M(+51.3%) | $225.80 M(+15.2%) |
| June 2005 | - | $47.46 M(+48.9%) | $195.98 M(+2.7%) |
| Mar 2005 | - | $31.88 M(-57.3%) | $190.85 M(+3.3%) |
| Dec 2004 | $184.83 M(+49.3%) | $74.67 M(+77.9%) | $184.83 M(+23.7%) |
| Sept 2004 | - | $41.97 M(-0.9%) | $149.46 M(+4.8%) |
| June 2004 | - | $42.34 M(+63.7%) | $142.66 M(+1.5%) |
| Mar 2004 | - | $25.86 M(-34.2%) | $140.62 M(+13.6%) |
| Dec 2003 | $123.77 M(-7.4%) | $39.29 M(+11.7%) | $123.77 M(-4.2%) |
| Sept 2003 | - | $35.17 M(-12.7%) | $129.14 M(-0.2%) |
| June 2003 | - | $40.29 M(+347.5%) | $129.37 M(-4.3%) |
| Mar 2003 | - | $9.00 M(-79.8%) | $135.25 M(+1.2%) |
| Dec 2002 | $133.66 M(+87.5%) | $44.67 M(+26.2%) | $133.66 M(+6.8%) |
| Sept 2002 | - | $35.40 M(-23.3%) | $125.09 M(+17.5%) |
| June 2002 | - | $46.18 M(+522.8%) | $106.51 M(+50.3%) |
| Mar 2002 | - | $7.41 M(-79.5%) | $70.88 M(-0.6%) |
| Dec 2001 | $71.30 M(+111.1%) | $36.10 M(+114.7%) | $71.30 M(+48.2%) |
| Sept 2001 | - | $16.82 M(+59.3%) | $48.12 M(+6.7%) |
| June 2001 | - | $10.55 M(+34.8%) | $45.11 M(+13.5%) |
| Mar 2001 | - | $7.83 M(-39.4%) | $39.73 M(+17.7%) |
| Dec 2000 | $33.77 M(-10.1%) | $12.92 M(-6.4%) | $33.77 M(+62.0%) |
| Sept 2000 | - | $13.81 M(+166.5%) | $20.85 M(+196.1%) |
| June 2000 | - | $5.18 M(+178.4%) | $7.04 M(+278.4%) |
| Mar 2000 | - | $1.86 M | $1.86 M |
| Dec 1999 | $37.57 M(+0.5%) | - | - |
| Dec 1998 | $37.38 M | - | - |
FAQ
- What is Charles River Laboratories International annual cash flow from operations?
- What is the all time high annual CFO for Charles River Laboratories International?
- What is Charles River Laboratories International annual CFO year-on-year change?
- What is Charles River Laboratories International quarterly cash flow from operations?
- What is the all time high quarterly CFO for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly CFO year-on-year change?
- What is Charles River Laboratories International TTM cash flow from operations?
- What is the all time high TTM CFO for Charles River Laboratories International?
- What is Charles River Laboratories International TTM CFO year-on-year change?
What is Charles River Laboratories International annual cash flow from operations?
The current annual CFO of CRL is $683.90 M
What is the all time high annual CFO for Charles River Laboratories International?
Charles River Laboratories International all-time high annual cash flow from operations is $760.80 M
What is Charles River Laboratories International annual CFO year-on-year change?
Over the past year, CRL annual cash flow from operations has changed by +$64.26 M (+10.37%)
What is Charles River Laboratories International quarterly cash flow from operations?
The current quarterly CFO of CRL is $251.79 M
What is the all time high quarterly CFO for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly cash flow from operations is $251.79 M
What is Charles River Laboratories International quarterly CFO year-on-year change?
Over the past year, CRL quarterly cash flow from operations has changed by +$30.85 M (+13.96%)
What is Charles River Laboratories International TTM cash flow from operations?
The current TTM CFO of CRL is $796.16 M
What is the all time high TTM CFO for Charles River Laboratories International?
Charles River Laboratories International all-time high TTM cash flow from operations is $796.16 M
What is Charles River Laboratories International TTM CFO year-on-year change?
Over the past year, CRL TTM cash flow from operations has changed by +$112.26 M (+16.41%)